The Effect of Levosimendan on Phosphine-Induced Nephrotoxicity: Biochemical and Histopathological Assessment

Abstract

Background Aluminum phosphide (AlP) toxicity is associated with a high risk of death due to heart, liver, and kidney failure as the target organs. Phosphine gas released due to the ingestion is the main factor involved in the multi-organ failure with various mechanisms. Levosimendan (LEV) is a calcium sensitizer with a pleiotropic effect on multiple organs. This study aimed to investigate whether LEV can alleviate AlP-induced nephrotoxicity in the rat model.

Method Six groups included control group (almond oil only), sole LEV group (48 µg/kg), AlP group (LD50=10 µg/kg), and the poisoned groups treated with LEV at doses of 12, 24, and 48 µg/kg 30 min after AlP gavage. After 24 hours of treatment, serum and kidney samples were taken for biochemical and histopathological analyses.

Result Biochemical analysis of the AlP group showed that the activity of complexes I, II, and IV was significantly reduced, while the levels of lipid peroxidation (LPO) and reactive oxygen species (ROS), lactate, and myeloperoxidase (MPO) activity significantly increased. Also, AlP reduced live renal cells and elevated necrosis. However, the levels of serum creatinine and blood urea nitrogen were not affected by the poisoning. LEV co-treatment could increase mitochondrial complex activity and reduce MPO activity, LPO, ROS, and lactate levels. Additionally, the histopathological analysis showed the detrimental effects of AlP on kidney tissue, which was mitigated by LEV administration.

Conclusion Our findings showed that LEV can potentially improve oxidative stress, imbalance in the redox status, necrosis, and pathological injuries in kidney tissue following AlP-poisoning.

Key words

Aluminum phosphide - levosimendan - mitochondria - nephrotoxicity - oxidative stress

• References

• 1 Goel A, Aggarwal P. Pesticide poisoning. National Medical Journal of India 2007; 20: 182
• 2 Haghi-Aminjan H, Baeeri M, Rahimifard M, Alizadeh A, Hodjat M, Hassani S. et al. The role of minocycline in alleviating aluminum phosphide-induced cardiac hemodynamic and renal toxicity. Environmental Toxicology and Pharmacology 2018; 64: 26-40
• 3 Jafari A, Baghaei A, Solgi R, Baeeri M, Chamanara M, Hassani S. et al. An electrocardiographic, molecular and biochemical approach to explore the cardioprotective effect of vasopressin and milrinone against phosphide toxicity in rats. Food and chemical toxicology 2015; 80: 182-192
• 4 Goharbari M, Taghaddosinejad F, Arefi M, Sharifzadeh M, Mojtahedzadeh M, Nikfar S. et al. Therapeutic effects of oral liothyronine on aluminum phosphide poisoning as an adjuvant therapy: A clinical trial. Human & experimental toxicology 2018; 37: 107-117
• 5 Bogale DE, Ejigu BD, Muche TA. Clinical Profile and Treatment Outcome of Aluminum Phosphide Poisoning in Felege Hiwot Referral Hospital, Northwest Ethiopia: A Retrospective Study. Open access emergency medicine : OAEM. 2021. 13. 239-248
• 6 Nili-Ahmadabadi A, Ali-Heidar F, Ranjbar A, Mousavi L, Ahmadimoghaddam D, Larki-Harchegani A. et al. Protective effect of amlodipine on diazinon-induced changes on oxidative/antioxidant balance in rat hippocampus. Research in pharmaceutical sciences 2018; 13: 368-376
• 7 Paraskevaidis IA, Parissis JT, Th Kremastinos D. Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: a novel mechanism of drug-induced improvement in contractile performance of the failing heart. Current Medicinal Chemistry-Cardiovascular & Hematological Agents 2005; 3: 243-247
• 8 Li L-L, Wei L, Zhang N, Wei W-Y, Hu C, Deng W. et al. Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway. BioMed Research International. 2020; 2020.
• 9 Yakut N, Yasa H, Bahrıye Lafcı B, Ortac R, Tulukoglu E, Aksun M. et al. The influence of levosimendan and iloprost on renal ischemia–reperfusion: an experimental study. Interactive cardiovascular and thoracic surgery 2008; 7: 235-239
• 10 Grossini E, Molinari C, Pollesello P, Bellomo G, Valente G, Mary D. et al. Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs. Journal of Pharmacology and Experimental Therapeutics 2012; 342: 376-388
• 11 Zager RA, Johnson AC, Lund S, Hanson SY, Abrass CK. Levosimendan protects against experimental endotoxemic acute renal failure. American Journal of Physiology-Renal Physiology 2006; 290: F1453-F1462
• 12 Gecit I, Kavak S, Yüksel MB, Basel H, Bektaş H, Gümrükçüoğlu HA. et al. Effect of short-term treatment with levosimendan on oxidative stress in renal tissues of rats. Toxicology and industrial health 2014; 30: 47-51
• 13 Abdelrahman AM, Al Suleimani Y, Shalaby A, Ashique M, Manoj P, Al-Saadi H. et al. Effect of levosimendan, a calcium sensitizer, on cisplatin-induced nephrotoxicity in rats. Toxicology reports 2019; 6: 232-238
• 14 Armandeh M, Bameri B, Baeeri M, Haghi-Aminjan H, Rahimifard M, Hassani S. et al. The role of levosimendan in phosphine-induced cardiotoxicity: evaluation of electrocardiographic, echocardiographic, and biochemical parameters. Toxicol Mech Methods. 2021:1-13
• 15 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry 1976; 72: 248-254
• 16 Janssen AJ, Trijbels FJ, Sengers RC, Smeitink JA, Van den Heuvel LP, Wintjes LT. et al. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clinical chemistry 2007; 53: 729-734
• 17 Tompkins AJ, Burwell LS, Digerness SB, Zaragoza C, Holman WL, Brookes PS. Mitochondrial dysfunction in cardiac ischemia–reperfusion injury: ROS from complex I, without inhibition. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 2006; 1762: 223-231
• 18 Smith L. Spectrophotometric assay of cytochrome c oxidase. Method Biochem Anal 1955; 2: 427-434
• 19 Abdolghaffari AH, Baghaei A, Solgi R, Gooshe M, Baeeri M, Navaei-Nigjeh M. et al. Molecular and biochemical evidences on the protective effects of triiodothyronine against phosphine-induced cardiac and mitochondrial toxicity. Life sciences 2015; 139: 30-39
• 20 Ranjbar A, Ghahremani MH, Sharifzadeh M, Golestani A, Ghazi-Khansari M, Baeeri M. et al. Protection by pentoxifylline of malathion-induced toxic stress and mitochondrial damage in rat brain. Human & experimental toxicology 2010; 29: 851-864
• 21 Nobakht-Haghighi N, Rahimifard M, Baeeri M, Rezvanfar MA, Moini Nodeh S, Haghi-Aminjan H. et al. Regulation of aging and oxidative stress pathways in aged pancreatic islets using alpha-lipoic acid. Molecular and Cellular Biochemistry 2018; 449: 267-276
• 22 Solgi R, Baghaei A, Golaghaei A, Hasani S, Baeeri M, Navaei M. et al. Electrophysiological and molecular mechanisms of protection by iron sucrose against phosphine-induced cardiotoxicity: a time course study. Toxicology Mechanisms and Methods 2015; 25: 249-257
• 23 Arora B, Punia R, Kalra R, Chugh S, Arora D. Histopathological changes in aluminium phosphide poisoning. Journal of the Indian Medical Association 1995; 93: 380-381
• 24 Anand R, Kumari P, Kaushal A, Bal A, Wani WY, Sunkaria A. et al. Effect of acute aluminum phosphide exposure on rats—A biochemical and histological correlation. Toxicology Letters 2012; 215: 62-69
• 25 Huang H-C, Tsai H-J, Wang C-C, Tsao C-M, Ka S-M, Liaw W-J. et al. Levosimendan mitigates coagulopathy and organ dysfunction in rats with endotoxemia. Journal of the Chinese Medical Association 2017; 80: 432-441
• 26 Zangrillo A, Alvaro G, Belletti A, Pisano A, Brazzi L, Calabrò MG. et al. Effect of levosimendan on renal outcome in cardiac surgery patients with chronic kidney disease and perioperative cardiovascular dysfunction: a substudy of a multicenter randomized trial. Journal of Cardiothoracic and Vascular Anesthesia 2018; 32: 2152-2159
• 27 Zhao RZ, Jiang S, Zhang L, Yu ZB. Mitochondrial electron transport chain, ROS generation and uncoupling. International Journal of Molecular Medicine 2019; 44: 3-15
• 28 Mohammadi M, Atashpour S, Pourkhalili N, Nili-Ahmadabadi A, Baeeri M, Mohammadirad A. et al. Comparative improvement in function of isolated rat Langerhans islets by various phosphodiesterase 3, 4 and 5 inhibitors. 2011; 6(12): 1233–40
• 29 Anger F, Paysant F, Brousse F, Normand IL, Develay P, Galliard Y. et al. Fatal aluminum phosphide poisoning. Journal of analytical toxicology 2000; 24: 90-92
• 30 Hajjej Z, Meddeb B, Sellami W, Labbene I, Morelli A, Ferjani M. Effects of levosimendan on cellular metabolic alterations in patients with septic shock: a randomized controlled pilot study. Shock (Augusta, Ga) 2017; 48: 307
• 31 Asghari MH, Moloudizargari M, Baeeri M, Baghaei A, Rahimifard M, Solgi R. et al. On the mechanisms of melatonin in protection of aluminum phosphide cardiotoxicity. Archives of toxicology 2017; 91: 3109-3120
• 32 Lall S, Sinha K, Mittra S, Seth S. An experimental study on cardiotoxicity of aluminium phosphide. Indian journal of experimental biology 1997; 35: 1060-1064
• 33 Askari H, Seifi B, Kadkhodaee M, Sanadgol N, Elshiekh M, Ranjbaran M. et al. Protective effects of hydrogen sulfide on chronic kidney disease by reducing oxidative stress, inflammation and apoptosis. EXCLI journal 2018; 17: 14
• 34 Miller F, Pozniak C, Walsh G. Neuronal life and death: an essential role for the p53 family. Cell Death & Differentiation 2000; 7: 880-888
• 35 Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arteriosclerosis, thrombosis, and vascular Biology 2005; 25: 1102-1111
• 36 Aminjan HH, Abtahi SR, Hazrati E, Chamanara M, Jalili M, Paknejad B. Targeting of oxidative stress and inflammation through ROS/NF-kappaB pathway in phosphine-induced hepatotoxicity mitigation. Life Sciences 2019; 232: 116607
• 37 Rogatzki MJ, Ferguson BS, Goodwin ML, Gladden LB. Lactate is always the end product of glycolysis. Frontiers in Neuroscience 2015; 9: 22
• 38 Dubin A, Maskin B, Murias G, Pozo MO, Sottile JP, Barán M. et al. Effects of levosimendan in normodynamic endotoxaemia: a controlled experimental study. Resuscitation 2006; 69: 277-286
• 39 Esch J, Joynt C, Manouchehri N, Lee T, Li Y-Q, Bigam D. et al. Differential hemodynamic effects of levosimendan in a porcine model of neonatal hypoxia-reoxygenation. Neonatology 2012; 101: 192-200